Beta2-microglobulin mutations in microsatellite unstable colorectal tumors

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• Defects in DNA mismatch repair (MMR) cause the high microsatellite instability (MSI-H) phenotype in cancers.
• MSI-H colorectal cancers (CRCs) exhibit high immunogenicity and often lose human leukocyte antigen (HLA) class I presentation due to beta-2-microglobulin (beta2m) gene mutations.
• These mutations can arise sporadically or in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome.

Purpose of the Study:

• To investigate the role and prevalence of beta2m mutations in the development and progression of MSI-H colorectal tumors.
• To explore the relationship between beta2m mutations, MMR gene status, and tumor stage in colorectal cancer.

Main Methods:

• Analysis of beta2m mutation frequency in MSI-H colorectal adenomas (n=38) and carcinomas (n=104).
• Comparison of mutation rates between sporadic and HNPCC-associated MSI-H CRCs.
• Correlation of beta2m mutations with tumor stage (UICC I-IV) and distant metastasis.

Main Results:

• Beta2m mutations were found in 15.8% of MSI-H adenomas and 27.9% of MSI-H CRCs.
• A higher frequency of beta2m mutations was observed in HNPCC-associated MSI-H CRCs (36.4%) compared to those without germline MMR mutations (15.4%).
• Beta2m mutations correlated positively with stage in non-metastatic tumors (UICC I-III) but were absent in metastatic CRCs (UICC IV).

Conclusions:

• Beta2m mutations are common in MSI-H colorectal tumors and are associated with immunoselection, particularly in HNPCC.
• Loss of beta2m expression may promote local progression of MSI-H colorectal tumors.
• Functional beta2m appears crucial for the formation of distant metastases in colorectal cancer.